Mercer Global Advisors Inc Summit Therapeutics Inc. Transaction History
Mercer Global Advisors Inc
- $45.6 Billion
- Q3 2024
A detailed history of Mercer Global Advisors Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 44,809 shares of SMMT stock, worth $872,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,809
Previous 47,251
5.17%
Holding current value
$872,431
Previous $368,000
166.58%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SMMT
# of Institutions
194Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$476 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$213 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$154 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$106 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$67.5 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.92B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...